Clinical trial
Safety and Efficacy of Lopinavir/Ritonavir in Combination With Raltegravir in HIV-infected Patients
NCT00752037 is registered in ClinicalTrials.gov with Saint Michael's Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Lopinavir/Ritonavir in Combination With Raltegravir in HIV-infected Patients
- Lead sponsor
- Saint Michael's Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- June 30, 2010
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.